MX9800217A - Macrolidos. - Google Patents

Macrolidos.

Info

Publication number
MX9800217A
MX9800217A MX9800217A MX9800217A MX9800217A MX 9800217 A MX9800217 A MX 9800217A MX 9800217 A MX9800217 A MX 9800217A MX 9800217 A MX9800217 A MX 9800217A MX 9800217 A MX9800217 A MX 9800217A
Authority
MX
Mexico
Prior art keywords
inclusive
positions
acid residue
macrocyclic ring
ring
Prior art date
Application number
MX9800217A
Other languages
English (en)
Other versions
MXPA98000217A (es
Inventor
Theodor Fehr
Lukas Oberer
Valerie Quesniaux Ryffel
Jean Jacques Sanglier
Walter Schuler
Richard Sedrani
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9513596.8A external-priority patent/GB9513596D0/en
Priority claimed from GBGB9515495.1A external-priority patent/GB9515495D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX9800217A publication Critical patent/MX9800217A/es
Publication of MXPA98000217A publication Critical patent/MXPA98000217A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona una clase novedosa de macrolidos en donde: i) las posiciones 2 a 6 inclusive del anillo macrociclico están provistas por un residuo de ácido piperidazinilcarboxílico; y/o ii) las posiciones 7 a 9 inclusive del anillo macrocíclico están provistas por un residuo de æ-aminoácido aromático; y/o iii) las posiciones 10 12 inclusive del anillo macrocíclico están provistas por un residuo de æ-aminoácido alifático, que comprende de preferencia 2, o especialmente los tres rasgos estructurales característicos i), ii), y iii), más especialmente un compuesto de la formula IX: (ver formula) que tienen propiedades inmunosupresoras y anti-inflamatorias, y formas protegidas y de anillo abierto de las mismas.
MXPA/A/1998/000217A 1995-07-04 1998-01-07 Macrolidos MXPA98000217A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9513596.8 1995-07-04
GBGB9513596.8A GB9513596D0 (en) 1995-07-04 1995-07-04 Organic compounds
GBGB9515495.1A GB9515495D0 (en) 1995-07-28 1995-07-28 Organic compounds
GB9515495.1 1995-07-28

Publications (2)

Publication Number Publication Date
MX9800217A true MX9800217A (es) 1998-07-31
MXPA98000217A MXPA98000217A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
AU708004B2 (en) 1999-07-29
HUP9802320A2 (hu) 1999-02-01
CZ424297A3 (cs) 1998-04-15
AU6519396A (en) 1997-02-05
NO980016D0 (no) 1998-01-02
JPH11509092A (ja) 1999-08-17
HUP9802320A3 (en) 1999-03-29
IL122844A0 (en) 1998-08-16
AR006514A1 (es) 1999-09-08
CO4750713A1 (es) 1999-03-31
BR9609324A (pt) 1999-05-25
CN1193979A (zh) 1998-09-23
KR19990028724A (ko) 1999-04-15
NO980016L (no) 1998-03-02
CA2224715A1 (en) 1997-01-23
EP0836616A1 (en) 1998-04-22
SK498A3 (en) 1998-07-08
TR199800001T1 (xx) 1998-04-21
PL324346A1 (en) 1998-05-25
WO1997002285A1 (en) 1997-01-23

Similar Documents

Publication Publication Date Title
AU678814B2 (en) Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
CA2145383A1 (en) O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
AU2420897A (en) Meta-substituted phenylene sulphonamide derivatives
AU2323897A (en) Cyclopropyl alkanoic acid derivatives
EP0930309A4 (en) TAXANE DERIVATIVES AND MEDICINES CONTAINING THEM
AU4211993A (en) Phenylimidazolidine derivatives, their preparation and their use
CA2270964A1 (en) Benzonaphthyridines as bronchial therapeutics
EP0397336A3 (en) Cell growth inhibitory macrocyclic lactone denominated combretastatin D-2
CA2311922A1 (en) Thienopyrimidines
TR199800001T1 (xx) Makrolidler.
AU4059485A (en) Substituted benzopyrans
ES2191364T3 (es) Agente tixotropico basado en una resina alquidica.
MY111439A (en) Thymosin alpha 1 derivatives
AU5316194A (en) New 17,20-epoxide derivatives of pregnane, their preparation, their use in the preparation of cortisone derivatives and intermediates
EP0702014A4 (en) DC-89 DERIVATIVES
AU1444695A (en) N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
AU3027697A (en) Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
AU1843197A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
AU2549099A (en) 24-hydroxyvitamin d derivatives
AU1843097A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
ES8704951A1 (es) Un procedimiento para la preparacion de nuevos derivados penem.
CA2277951A1 (en) Imino-aza-anthracyclinone derivatives
ZA949595B (en) Glutaramide derivatives
CA2123101A1 (en) Nitroxyalkylamide derivative
SE1214315T3 (es)